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Background: Bushen-Qiangdu-Zhilv Decoction (BQZ) is one of famous traditional Chinese medical formula for
treating ankylosing spondylitis (AS). However, the mechanisms underlying effects of BQZ remains unknown.
Pro-inflammatory cytokines, tumor necrosis factor (TNF)-α and interleukin (IL)-1, play an important role in AS. We
therefore evaluated if BQZ could affect the expression of these cytokines.
Methods: Crude extracts were prepared and fractioned with petroleum ether (PE), ethyl acetate (EA), n-butanol
(BU) and finally water (ACE). The stability of the extracts was confirmed by high-pressure liquid chromatography
(HPLC) analysis. M1-polarized RAW264.7 was induced and subsequently treated with BQZ extracts. Quantitative
real-time PCR experiments were performed to measure mRNA expression of TNF-α and IL-1.
Results: It was found that TNF-α could be significantly suppressed by ACE extracts, whereas IL-1 was dramatically
inhibited by BU extracts, which was further confirmed by dose-dependent experiments. Importantly, MTS assays
showed that both ACE and BU extracts had a low cytotoxicity.
Conclusion: Altogether, our study indicates that BQZ decoction exerts anti-AS effects via its anti-inflammatory
activity and may have a low side-effect. Further analysis of the extracts of BQZ decoction could lead to a discovery
of some novel drugs adding to therapeutic strategy for AS patients.Background
Ankylosing spondylitis (AS) is a systemic inflammatory
disease characterized by chronic inflammation of the
axial skeleton, the peripheral joints, enthuses as well as
the attachments of ligaments [1]. The prevalence of AS
is 0.20%–0.54% among Han-Chinese population, which
is similar to the prevalence in Europe and America [2].
Regarding therapeutic approaches aimed to treat AS,
nonsteroidal anti-inflammatory drugs (NSAIDs) have been
considered as the cornerstone of treatment for AS, but still,
they are not effective in some cases. Disease-modifying
antirheumatic drugs (DMARDs), such as sulfasalazine and
methotrexate, are only recommended for treating AS with
peripheral arthritis or extra-articular features [3,4]. How-
ever, in cases of exclusive spinal involvement that do not* Correspondence: yitinghe@126.com
1Department of Rheumatology, The Second Affiliated Hospital, Guangzhou
University of Chinese Medicine (Guangdong Provincial Hospital of Chinese
Medicine), Guangzhou 510006, China
Full list of author information is available at the end of the article
© 2014 Huang et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.respond to NSAIDs, the merely option is to adopt anti-
tumor necrosis factor (TNF) agents [4]. Because anti-TNF
therapy suppresses the immune system [5], serious infec-
tions are the most frequently reported adverse events of
interest across indications for the anti-TNF drugs [6]. In
addition, given the role of TNF in mediating tumor
growth [5], the risk of malignancy with anti-TNF therapy
has been a concern [7], and there is substantial evidence
that the chronic inflammation inherent in the conditions
treated with anti-TNF therapy is itself associated with an
increased potential for malignancy [6,8].
Fortunately, traditional Chinese medicine provides an
alternative, or better, choice for AS patients. For example,
traditional Chinese medical treatment, while effective in
treating rheumatoid arthritis, appears to be less effective
than Western medical treatment in controlling symptoms,
but traditional Chinese medical treatment is associated
with fewer side effects [9]. Bushen-Qiangdu-Zhilv Decoction
(BQZ) was established by Prof. Shu-De Jiao who is a
well-known traditional Chinese medicine master inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 The components of BQZ formula
Components of formula Quantity
Rhizoma Drynariae 18 g
Fructus psoraleae 12 g
Radix Rehmanniae Praeparata 15 g
Herba epimedii 12 g
Notopterygium root 12 g
Rhizome cibotii 30 g
Radix angelicae pubescentis 10 g
Dipsacus root 18 g
Eucommia ulmoides 20 g
Medicinal cyathula root 12 g
Herba lycopi 15 g
Cassia twig 15 g
Rhizome anemarrhenae 15 g
Radix aconiti carmichaeli (Cooked and sliced) 12 g
honey-fried herba ephedrae 6 g
Rhizome zingiberis 6 g
Rhizoma atractylodis macrocephalae 10 g
Radix clematidis 15 g
Radix Saposhnikoviae 12 g
Raw semen coicis 30 g
Root of common peony 12 g
Radix paeoniae alba 12 g
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strated to be more effective than sulfasalazine, a typical
DMARD for treating AS, in relieving clinical symptoms
and signs as well as inflammatory activity indicators of AS
patients [10]. However, the mechanisms underlying BQZ
decoction effects remains unclear. Herein, in this study,
the crude extracts of BQZ decoction was prepared and
fractioned, and effects of crude extracts of BQZ decoction
on pro-inflammatory cytokines, TNF-α and interleukin
(IL)-1, were determined.
Methods
Cell lines and cell culture
RAW 264.7 macrophage-like cell line was ordered from
American Type Culture Collection (Rockville, MD, USA)
and cultured in Dulbecco’s Modified Eagle’s Medium sup-
plemented with 10% fetal bovine serum (FBS). To induce
M1-polarized RAW264.7, 100 ng/ml interferon (IFN)-γ
was added to cultures for 24 h prior to stimulation with
crude extracts of BQZ decoction. Cell lines were propa-
gated at 37°C in an atmosphere of 5% CO2.
Extraction and separation
Bushen-Qiangdu-Zhilv (BQZ) formula is composed of
22 species of herbal plants. All components, purchased
from KANGMEI pharmaceutical Co., LTD (Guangzhou,
China), were identified by our authors (Prof. Yi-Ting He
and Dr. Xiao-Hong He). The formula of BQZ is described
in Table 1.
Total 352 g of BQZ formula was boiled with 1.5 L
ultrapure water in a Chinese medicine decocting pot
(Guangzhou WEN XIN electronics co., LTD., China)
for 2 h, yielding final 400 ml of solution. The obtained
solution was filtered and subsequently dried using a
centrifugal evaporator (Genevac Ltd., UK) for 48 h,
following evaporated in a rotavapor (IKA laboratory,
Germany) at 25°C. Finally, 6.4 g crude extract of BQZ
decoction was obtained.
6.4 g of the crude extract were suspended in 400 ml
ultrapure water and the solution was extracted three
times with 500 ml of solvents of different polarity starting
with petroleum ether (PE), ethyl acetate (EA), n-butanol
(BU) and finally water (ACE). The obtained fractions were
evaporated to dryness yielding 0.09 g petroleum ether,
0.72 g ethyl acetate, 0.549 g n-butanol and 4.50 g water
fraction. High-pressure liquid chromatography (HPLC)
analysis was performed as previously described [11]. To
observe which fractioned extracts is responsible for the
BQZ effects, 50 μg/ml of these crude extracts were used
to stimulate M1-polarized RAW264.7 for 24 h.
Flow cytometric analysis
The M1 polarized RAW264.7 was washed with PBS, and
cells were subsequently stained with FITC-conjugatedantibody, directed against cell surface marker CD86 [12],
or with corresponding isotype controls for 20 min at
4°C. Cells were analyzed using FACSCalibur (Becton
Dickinson, Erembodegem, Belgium). Data were analyzed
using fluorescence-activated cell sorting (FACS) analysis
and shown as mean fluorescent intensity (MFI).
Reverse transcriptase and quantitative real-time PCR
Total RNA was extracted using Trizol reagent (Invitrogen,
Grand Island, NY), and cDNA was subsequently synthe-
sized from 2 μg of total RNA using a high capacity cDNA
reverse transcription kit (Promega, Madison, WI), ac-
cording to the manufacturer’s instruction. Quantitative
real-time PCR was performed using gene-specific primers
and SYBR Green qPCR SuperMix (Bio-Rad Laboratories,
Inc. Berkeley, CA). The following primer sequences were
used: GAPDH, (forward) 5′-GTTTTCAGGGATGAAGC
GGC-3′and (reverse) 5′-TTTGTCAAGCTCATTTCCTG
GTATG-3′; TNF-ɑ, (forward) 5′-GTGTCCCAACATTC
ATATTGTCAGT-3′and (reverse) 5′-TGGGAAGAGAAA
CCAGGGAGA-3′; IL-1, (forward) 5′-TGGGATAGGGC
CTCTCTTGC-3′and (reverse) 5′-CCATGGAATCCGTG
TCTTCCT-3′; arg1, (forward) 5′-TACAAGACAGGGCT
CCTTTCAG-3′and (reverse) 5′-TGAGTTCCGAAGCA
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AAGCCAA-3′and (reverse) 5′-AGACCTCAACAGAGCC
CTCA-3′.
Real-time PCR was performed using the CFX96 Touch
Deep Well™ Real-Time PCR Detection System (Bio-Rad)
with the following steps: 50°C 2 min, 95°C 10 min, 40 cycles
at 95°C 15 s and 60°C 60 s. The expression of target genes
in the treatment and control groups was normalized using
the house-keeping gene GAPDH and the fold change in
the expression of each target gene was calculated by the
2-ΔΔCT method.
Cytotoxicity assay
Cytotoxicity of ACE and BU extracts was detected by
MTS, i.e., CellTiter 96® AQueous One Solution Cell Prolif-
eration Assay, according to the manufacturer’s instruction
(Promega). Briefly, cells were seeded at the same density
into 96-well plates and incubated overnight for attaching.
After proper treatment, the control and treated cells were
incubated for the indicated times. Following adding 20 μl
of MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt]
in each micro well, and plate was read using a microplate
reader at wavelength of 492 nm (Bio-Rad, Philadelphia,
PA, USA).
Statistical analyses
Data are shown as means ± SD from experiments repeated
at least twice. For the comparisons between two groups,
Student's t test was utilized. One-way ANOVA followed
by Dunnett’s test was employed for comparisons among
more than two groups. Statistical analyses were conducted
by SPSS 11.6 statistical software (SPSS, Chicago, IL). A
two-tailed P value of < 0.05 was considered to indicate
statistical significance.
Results
In vitro M1 macrophage polarization
M1 macrophage phenotype was induced on RAW264.7
by stimulating with 100 ng/ml IFN-γ for 24 h (Figure 1A).
Flow cytometric analysis were conducted to examine
CD86 expression in cell surface, since CD86 is well-known
to be a signature marker of M1 macrophage. As shown in
Figure 1B, CD86 was expressed in 96.5% RAW264.7 ex-
posed to IFN-γ, confirming M1 polarization of RAW264.7.
Real-time PCR further confirmed the data obtained by flow
cytometric analysis. The overall polarization of RAW264.7
shifted to M1, as inducible nitric oxide synthase (iNOS)
expression increased and arginase (Arg)-1 expression de-
creased (Figure 1C) [12].
Effects of crude extracts on TNF-α and IL-1 mRNA expression
The crude extracts, including extracts fractioned by
PE, EA, BU and finally ACE, were used to treat theM1-polarized macrophages. PE extracts was not used,
since cells were totally killed when treating with PE
extracts. M1-polarized RAW264.7 was stimulated with
50 μg/ml of these crude extracts for 24 h respectively.
M1-polarized RAW264.7 without treatment was used
as the controls. Total RNA was extracted from cell
lysates and subjected to quantitative real-time PCR
experiments. As shown in Figure 2A, ACE extracts sig-
nificantly suppressed mRNA expression of TNF-α by
about 4.0-fold of control with p < 0.01. In addition, EA
extracts reduced TNF-α mRNA expression by about
2.0-fold of control (p < 0.05). However, both ACE and
EA extracts did not have significant effects on IL-1
mRNA expression (Figure 2B). Interestingly, BU extracts
had an opposite effects. The level of IL-1 mRNA, but not
TNF-α mRNA was dramatically decreased by BU extracts
by more than 7.0-fold of control (Figure 2B, p < 0.01).
Herein, it appears that EA extracts are responsible for
targeting TNF-α, while BU extracts are accountable for
suppressing IL-1 in BQZ decoction. Further experiments
were conducted to verify the effects of EA and BU extracts
on pro-inflammatory cytokines.
The preparation of crude extracts and the subsequently
HPLC experiments were performed more than three
times. As illustrated in Figure 3, HPLC chromatograms of
total, ACE and BU extracts of BQZ decoction prepared
from three independent experiments were quite similar,
suggesting the stability of the extracts and the preparation
technology.
ACE extracts suppressed TNF-α expression with a low
cytotoxicity
To confirm the suppressing effects of ACE extracts on
mRNA expression of TNF-α in M1-polarized phenotype,
RAW264.7 was treated with graded levels of ACE
extracts following 24 h stimulation with 100 ng/ml
IFN-γ. As shown in Figure 4A, mRNA level of TNF-α was
suppressed by ACE extracts in a dose-dependent manner.
The expression of TNF-α mRNA was almost completely
inhibited when cells exposed to ACE extracts at the
concentrations from 100 μg/ml to 500 μg/ml (p < 0.001
respectively).
To determine if the decreased levels of TNF-α mRNA
were due to cell death, cells survival was examined by
MTS assays. MTS assay is an update method from MTT
assay, which is a typical and widely used tool for measure-
ment of cell survival. After stimulation with 100 ng/ml
IFN-γ, RAW264.7 was treated graded levels of ACE extracts
for 24 h and MTS experiments were subsequently con-
ducted. Surprisingly, ACE extracts did not affect cell sur-
vival significantly, even at the concentration of 500 μg/ml
(Figure 4B). Our findings suggest that ACE extracts can
suppress expression of TNF-α mRNA in M1-polarized
RAW264.7 with a low cytotoxicity.
Figure 1 Induction of M1-polarized RAW264.7. RAW264.7 was polarized toward the M1 phenotype by stimulating with 100 ng/ml IFN-γ for
24 h. A, microscope shots pictures of RAW264.7. The right panel is the M1 phenotype. B, flow cytometry detection of CD86, a signature marker of
M1 cells. C, the relative mRNA levels of iNOS and Arg-1 were determined by real-time PCR. The mRNA levels of these two molecules in RAW264.7
without treatment were used as the controls. Data are presented as mean ± SD of three independent experiments done in triplicate. **p < 0.05
and ***P < 0.001 versus control.
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cytotoxicity
RAW264.7 was treated with increasing concentrations
of BU extracts following 24 h stimulation of 100 ng/ml
IFN-γ. Figure 5A showed that BU extracts could dose-
dependently inhibit IL-1 mRNA expression. 50 μg/ml BU
extracts significantly suppressed IL-1 mRNA expression(p < 0.05), which is in line with the data shown in
Figure 2B. In addition, BU extracts totally abrogated the
increased expression of IL-1 mRNA in M1-polarized
RAW64.7 to the level under control (p < 0.001). MTS as-
says demonstrated that increasing concentrations of BU
extracts could not kill M1-polarized RAW2647, albeit
there was an inhibitory trend (Figure 5B). Together, these
Figure 2 Effects of fractioned extracts on TNF-α and IL-1 mRNA expression. Quantitative real-time PCR evaluation for the effects of crude
extracts of BQZ decoction on mRNA expression of TNF-α (A) and IL-1 (B). M1-polarized RAW264.7 was stimulated with the different crude extracts
(50 μg/ml respectively) for 24 h. The M1-polarized RAW2647 without extracts stimulation were used as control and RAW264.7 without treatment
were employed as the additional controls. Total RNA was extracted and subjected to real-time PCR experiments. Data are expressed as mean ± SD
of three independent experiments done in triplicate. *p < 0.01 and **P < 0.01 versus the additional controls, while #p < 0.05 and ##p < 0.01
versus control.
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IL-1 expression with a low cytotoxicity.
Discussion
Macrophage activation plays an important role in the
pathology of AS [7,10,13]. Macrophages are a population
of cells derived from CD34 positive bone marrow progeni-
tors, from which blood pro-monocytes are differentiated
and developed into monocytes which extravasate into
tissues where they become “resident” tissue macrophagesFigure 3 The stability of the extracts and the preparation technology
analyzed using a liquid chromatograph. Figures shown were selected from[14]. Macrophages may be recruited and subsequently ac-
tivated as consequence of any local disturbance of tissue
homeostasis, such as infections, immune response and
malignancy [7,15]. Activated macrophages, also known as
polarized macrophages, present different phenotypes, M1
(classical activation) and M2 (alternative activation) in
general, in relation to the nature of the recruiting stimulus
and the location [7,16]. These two polarized phenotypes
are considered to exhibit opposing activities, being either
polarized towards pro-inflammatory or anti-inflammatory. Total crude extracts (A), ACE extracts (B) and BU extracts (C) was
the experiments repeated for four times.
Figure 4 ACE extracts suppressed TNF-α expression with a low cytotoxicity. M1-polarized RAW264.7 was treated graded levels of ACE
extracts for 24 h. A. Real-time PCR evaluation of TNF-α mRNA expression in M1-polarized RAW264.7. RAW264.7 without treatment was used as
the additional controls. *p < 0.01 and **P < 0.01 versus RAW264.7 cells without treatment, while #p < 0.05 and ##p < 0.01 versus M1-polarized
macrophages without treatment. B. The cytotoxicity of ACE extracts was determined by MTS assay, and the results were presented as% of
controls. Data are expressed as mean ± SD of three independent experiments done in triplicate.
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TNF-α and IL-1, are derived from M1-polarized macro-
phages, and importantly these cytokines are associated
with AS [17,18]. Moreover, M1-polarized macrophages
have been demonstrated to be expanded in AS patients
[5]. Mouse macrophage-like cell line RAW264.7 is, to
some extent, an ideal macrophage model for in-vitro
studies [19]. Therefore, in this study, RAW264.7 was
used as an in-vitro model, and M1 phenotype was polarized
by exposure to IFN-γ [19].
Biological agents targeting inflammatory cytokines such
as TNF-α have widely used in recent years as effective
medications for treating AS, while numerous cases of the
appearance of malignant tumors in patients receiving
these drugs have been reported [20]. In addition, not all
AS patients achieve remission or a major clinical response
to NSAIDs and TNF-α blockers [21]. Though biological
agents targeting IL-1, anakinra for example, has proven to
be well tolerated and indicated in the treatment ofFigure 5 BU extracts suppressed IL-1 expression with a low cytotoxic
for 24 h. A. Real-time PCR evaluation of IL-1 mRNA expression in M1-polari
controls. *p < 0.01 and **P < 0.01 versus RAW264.7 without treatment, whil
treatment. B. The cytotoxicity of BU extracts was determined by MTS assay
mean ± SD of three independent experiments done in triplicate.rheumatoid arthritis, the data in AS are still lacking.
Therefore, are there any alternatives?
BQZ decoction is a famous Chinese medicine formula
with a long history for application in the treatment of
AS. Crude extracts was prepared from BQZ decoction
and subsequently fractioned. The effects of different
fractioned extracts on the expression of pro-inflammatory
cytokines were screened. Strikingly, in M1-polarized
RAW264.7, ACE extracts could significantly suppress
mRNA level of TNF-α, whereas BU extracts dramatic-
ally inhibited IL-1 mRNA expression. These findings
suggest that BQZ decoction could be a natural antag-
onist to pro-inflammatory cytokines. To confirm this
data, concentration-dependent experiments were con-
ducted subsequently. The discovery of that TNF-α
mRNA expression could be totally inhibited by ACE
extracts suggests that BQZ decoction can be an alter-
native medication in AS patients intolerance to TNF-α
blockers [21].ity. M1-polarized RAW264.7 was treated graded levels of BU extracts
zed RAW264.7. RAW264.7 without treatment was used as the additional
e #p < 0.05 and ##p < 0.01 versus M1-polarized RAW264.7 without
, and the results were presented as% of controls. Data are expressed as
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lead to extensive new bone formation throughout the
spine [22], and importantly, IL-1 may result in stimula-
tion of bone formation [23,24]. The data that expression
of IL-1 mRNA was completely blocked by BU extracts
implies that BQZ decoction is capable of relieving new
bone formation. Therefore, BQZ decoction might be a
better medication than many other biological agents
targeting TNF-α, such as infliximab, etanercept, adalimu-
mab, as the treatment of these agents does not halt new
bone formation [25].
In addition, we tested if the decrease of TNF-α and
IL-1 was due to the death of cells. Herein, MTS assays
were conducted and the results turned out to be negative.
Both ACE and BU extracts could not induce cell death in
M1-polarized RAW264.7, suggesting the low cytotoxicity
of the extracts of BQZ decoction. Considering modified
BQZ decoction was more efficacious than sulfasalazine
[10], the lower cytotoxicity of the extracts of BQZ decoc-
tion suggests that, compared with those Western medica-
tions, traditional Chinese medications could be a safer and
better choice for treating AS.Conclusion
In summary, with the low cytotoxicity, crude extracts of
BQZ decoction fractioned with ACE and BU could block
TNF-α and IL-1 mRNA expression in M1-polarized
RAW264.7 respectively, suggesting that BQZ decoction
could be an better and alternative medication for treating
AS patients. Further analysis of fractioned extracts of BQZ
decoction may lead to some novel drugs for treating AS
with more efficacious and low toxicity.
Competing interests
The authors declared that they have no competing interests.
Authors’ contributions
Conceived and designed the experiments: YTH and RYH. Performed the
experiments: RYH, JHL, XHH, XL, CLL, YYZ and JC; Analyzed the data: RYH
and YTH; Contributed reagents/materials/analysis tools: YTH; Wrote the
manuscript: RYH; Reviewed paper: YTH. All authors read and approved the
final manuscript.
Acknowledgments
This study was supported by National Natural Science Foundation of China
(No. 81273736).
Author details
1Department of Rheumatology, The Second Affiliated Hospital, Guangzhou
University of Chinese Medicine (Guangdong Provincial Hospital of Chinese
Medicine), Guangzhou 510006, China. 2Central Laboratory, The Second
Affiliated Hospital, Guangzhou University of Chinese Medicine (Guangdong
Provincial Hospital of Chinese Medicine), Guangzhou 510006, China.
3Department of Cerebral Surgery, The Second Affiliated Hospital, Guangzhou
University of Chinese Medicine (Guangdong Provincial Hospital of Chinese
Medicine), Guangzhou 510006, China.
Received: 22 May 2014 Accepted: 17 July 2014
Published: 28 July 2014References
1. Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Blanco
R, Pina T, González-Juanatey C, Llorca J, González-Gay MA: Adipokines,
Biomarkers of Endothelial Activation, and Metabolic Syndrome in
Patients with Ankylosing Spondylitis. Biomed Res Int 2014, 2014:860651.
2. Zhai J, Rong J, Li Q, Gu J: Immunogenetic study in Chinese population
with ankylosing spondylitis: are there specific genes recently disclosed?
Clin Dev Immunol 2013, 2013:419357.
3. Slobodin G, Rosner I, Rimar D, Boulman N, Rozenbaum M, Odeh M:
Ankylosing spondylitis: field in progress. Isr Med Assoc J 2012, 14:763–767.
4. Senabre-Gallego JM, Santos-Ramírez C, Santos-Soler G, Salas-Heredia E,
Sánchez-Barrioluengo M, Barber X, Rosas J, AIRE-MB group: Long-term
safety and efficacy of etanercept in the treatment of ankylosing
spondylitis. Patient Prefer Adherence 2013, 7:961–972.
5. Ciccia F, Alessandro R, Rizzo A, Accardo-Palumbo A, Raimondo S, Raiata F,
Guggino G, Giardina A, De Leo G, Sireci G, Triolo G: Macrophage phenotype
in the subclinical gut inflammation of patients with ankylosing spondylitis.
Rheumatology (Oxford) 2014, 53:104–113.
6. Baczynska D, Michalowska D, Witkiewicz W: The role of microRNA in
ischemic diseases–impact on the regulation of inflammatory, apoptosis
and angiogenesis processes. Przegl Lek 2013, 70:135–142. Article in Polish.
7. Maruotti N, Annese T, Cantatore FP, Ribatti D: Macrophages and
angiogenesis in rheumatic diseases. Vasc Cell 2013, 5:11.
8. Mizia-Malarz A, Sobol G, Wos H: Angiogenesis in the chronic inflammatory
diseases and malignancies. Pol Merkur Lekarski 2008, 24:185–189.
Article in Polish.
9. He YT, Ou AH, Yang XB, Chen W, Fu LY, Lu AP, Yan XP, Feng XH, Su L, Song
YJ, Zeng SP, Liu W, Qian X, Zhu WH, Lao YR, Xu WH, Wen ZH, He XH, Wang
BJ, Chen GX, Xue SQ: Traditional Chinese medicine versus western
medicine as used in China in the management of rheumatoid arthritis: a
randomized, single-blind, 24-week study. Rheumatol Int 2014, 24. Epub
ahead of print.
10. Szekanecz Z, Koch AE: Mechanisms of disease: angiogenesis in
inflammatory diseases. Nat Clin Pract Rheumatol 2007, 3:635–643.
11. Li X, Zhang Y, Zeng X, Yang L, Deng Y: Chemical profiling of bioactive
constituents in Sarcandra glabra and its preparations using ultra-
high-pressure liquid chromatography coupled with LTQ Orbitrap
mass spectrometry. Rapid Commun Mass Spectrom 2011, 25:2439–2447.
12. Davis MJ, Tsang TM, Qiu Y, Dayrit JK, Freij JB, Huffnagle GB, Olszewski MA:
Macrophage M1/M2 polarization dynamically adapts to changes in
cytokine microenvironments in Cryptococcus neoformans infection. mBio
2013, 4:e00264–00213.
13. Alvarez-Navarro C, de Lopez Castro JA: ERAP1 structure, function and
pathogenetic role in ankylosing spondylitis and other MHC-associated
diseases. Mol Immunol 2014, 57:12–21.
14. Singh A, Talekar M, Raikar A, Amiji M: Macrophage-targeted delivery
systems for nucleic acid therapy of inflammatory diseases. J Control
Release 2014, 14:00239–9.
15. Kharraz Y, Guerra J, Mann CJ, Serrano AL, Munoz-Canoves P: Macrophage
plasticity and the role of inflammation in skeletal muscle repair.
Mediators Inflamm 2013, 2013:491497.
16. Locati M, Mantovani A, Sica A: Macrophage activation and polarization as
an adaptive component of innate immunity. Adv Immunol 2012,
120:163–184.
17. Monnet D, Kadi A, Izac B, Lebrun N, Letourneur F, Zinovieva E, Said-Nahal R,
Chiocchia G, Breban M: Association between the IL-1 family gene cluster
and spondyloarthritis. Ann Rheum Dis 2012, 71:885–890.
18. Lea WI, Lee YH: The associations between interleukin-1 polymorphisms
and susceptibility to ankylosing spondylitis: a meta-analysis. Joint Bone
Spine 2012, 79:370–374.
19. Hiroi M, Sakaeda Y, Yamaguchi H, Ohmori Y: Anti-inflammatory cytokine
interleukin-4 inhibits inducible nitric oxide synthase gene expression in
the mouse macrophage cell line RAW264.7 through the repression of
octamer-dependent transcription. Mediators Inflamm 2013, 2013:369693.
20. Sifuentes Giraldo W, Gonzalez Garcia A, Tojeiro SC, Sanchez-Sanchez O, Pian H,
Diaz MV: Colonic perforation secondary to metastatic lung adenocarcinoma
during anti-TNF treatment for ankylosing spondylitis. Acta Reumatol Port
2014, 39:72–76.
21. Kiltz U, Heldmann F, Baraliakos X, Braun J: Treatment of ankylosing
spondylitis in patients refractory to TNF-inhibition: are there alternatives?
Curr Opin Rheumatol 2012, 24:252–260.
Huang et al. BMC Complementary and Alternative Medicine 2014, 14:268 Page 8 of 8
http://www.biomedcentral.com/1472-6882/14/26822. Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, King L, Poole
AR, Inman RD: Cartilage biomarkers in ankylosing spondylitis: relationship
to clinical variables and treatment response. Arthritis Rheum 2005,
52:885–891.
23. Strand V, Kavanaugh AF: The role of interleukin-1 in bone resorption in
rheumatoid arthritis. Rheumatology (Oxford) 2004, 43(3):iii10–iii16.
24. Watrous DA, Andrews BS: The metabolism and immunology of bone.
Semin Arthritis Rheum 1989, 19:45–65.
25. Hreggvidsdottir HS, Noordenbos T, Baeten DL: Inflammatory pathways in
spondyloarthritis. Mol Immunol 2014, 57:28–37.
doi:10.1186/1472-6882-14-268
Cite this article as: Huang et al.: Anti-inflammatory activity of extracts
of Bushen-Qiangdu-Zhilv decoction, a Chinese medicinal formula,
in M1-polarized RAW264.7. BMC Complementary and Alternative
Medicine 2014 14:268.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
